banner add

New N.I.H. Policy Threatens Global Science Collaborations

Restrictions on payments to foreign partners may jeopardize studies of cancer and other conditions that would benefit Americans.

from NYT > Health https://ift.tt/mbiYhuI
via IFTTT

No comments

China’s Rise in Drug Development Looms Over U.S.

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is ...

Theme images by PLAINVIEW. Powered by Blogger.